Profil
Blagoje Murganić
Zvanje:
Istraživač saradnik
Direktni telefoni:
Lokal:
Naučna oblast:
1
Veće oblasti:
Orcid broj:
Organizaciona jedinica:
080
DIPLOME
ZVANJA
M faktor
| Kategorija | Broj | Koeficijent | Ukupno |
|---|---|---|---|
| M11 | 0 | 14 | 0 |
| M12 | 0 | 10 | 0 |
| M13 | 0 | 7 | 0 |
| M14 | 0 | 4 | 0 |
| M15 | 0 | 3 | 0 |
| M16 | 0 | 2 | 0 |
| M17 | 0 | 3 | 0 |
| M18 | 0 | 2 | 0 |
| M21a | 0 | 10 | 0 |
| M21 | 3 | 8 | 24 |
| M22 | 5 | 5 | 25 |
| M23 | 0 | 3 | 0 |
| M24 | 0 | 2 | 0 |
| M25 | 0 | 1.5 | 0 |
| M26 | 0 | 1 | 0 |
| M27 | 0 | 0.5 | 0 |
| M28a | 0 | 3.5 | 0 |
| M28b | 0 | 2.5 | 0 |
| M29a | 0 | 1.5 | 0 |
| M29b | 0 | 1.5 | 0 |
| M29v | 0 | 1 | 0 |
| M31 | 0 | 3.5 | 0 |
| M32 | 0 | 1.5 | 0 |
| M33 | 0 | 1 | 0 |
| M34 | 7 | 0.5 | 3.5 |
| M35 | 0 | 0.3 | 0 |
| M36 | 0 | 1.5 | 0 |
| M41 | 0 | 7 | 0 |
| M42 | 0 | 5 | 0 |
| M43 | 0 | 3 | 0 |
| M44 | 0 | 2 | 0 |
| M45 | 0 | 1.5 | 0 |
| M46 | 0 | 1 | 0 |
| M47 | 0 | 0.5 | 0 |
| M48 | 0 | 2 | 0 |
| M49 | 0 | 1 | 0 |
| M51 | 0 | 2 | 0 |
| M52 | 1 | 1.5 | 1.5 |
| M53 | 0 | 1 | 0 |
| M54 | 0 | 0.2 | 0 |
| M55 | 0 | 1 | 0 |
| M56 | 0 | 0.3 | 0 |
| M57 | 0 | 0.2 | 0 |
| M61 | 0 | 1.5 | 0 |
| M62 | 0 | 1 | 0 |
| M63 | 0 | 1 | 0 |
| M64 | 1 | 0.2 | 0.2 |
| M65 | 0 | 0 | 0 |
| M66 | 0 | 1 | 0 |
| M67 | 0 | 0 | 0 |
| M68 | 0 | 0 | 0 |
| M69 | 0 | 0 | 0 |
| M71 | 0 | 6 | 0 |
| M72 | 0 | 3 | 0 |
| M81 | 0 | 0 | 0 |
| M82 | 0 | 0 | 0 |
| M83 | 0 | 0 | 0 |
| M84 | 0 | 0 | 0 |
| M85 | 0 | 0 | 0 |
| M86 | 0 | 0 | 0 |
| M87 | 0 | 0 | 0 |
| M91 | 0 | 0 | 0 |
| M92 | 0 | 0 | 0 |
| M93 | 0 | 0 | 0 |
| M94 | 0 | 0 | 0 |
| M95 | 0 | 0 | 0 |
| M96 | 0 | 0 | 0 |
| M97 | 0 | 0 | 0 |
| M98 | 0 | 0 | 0 |
| M99 | 0 | 0 | 0 |
| M101 | 0 | 0 | 0 |
| M102 | 0 | 0 | 0 |
| M103 | 0 | 0 | 0 |
| M104 | 0 | 0 | 0 |
| M105 | 0 | 0 | 0 |
| M106 | 0 | 0 | 0 |
| M107 | 0 | 0 | 0 |
| M108 | 0 | 0 | 0 |
| M109 | 0 | 0 | 0 |
| M110 | 0 | 0 | 0 |
| M111 | 0 | 0 | 0 |
| M112 | 0 | 0 | 0 |
| M121 | 0 | 3 | 0 |
| M122 | 0 | 2 | 0 |
| M123 | 0 | 1 | 0 |
| M124 | 0 | 1 | 0 |
Ukupno M faktor:
54.2
NI radovi
| # | Naziv, Datum, Grupa, Vrsta | Godina | Autori | Status | Akcija |
|---|---|---|---|---|---|
| 1 |
Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in HCT116 Cells
ChemMedChem , , 2018 M20 | M21 |
2018 | Dr. Robert Kuhnert, Dr. Menyhárt-Botond Sárosi, Sven George, Dr. Peter Lönnecke, Dr. Bettina Hofmann, Prof. Dr. Dieter Steinhilber, Sara Steinmann, Prof. Dr. Regine Schneider-Stock, Blagoje Murganić, Prof. Dr. Sanja Mijatović, Prof. Dr. Danijela Maksimović-Ivanić, Prof. Dr. Dr. h.c. mult. Evamarie Hey-Hawkins |
Odobren
|
|
| 2 |
Carboranyl Derivatives of Rofecoxib with Cytostatic Activity against Human Melanoma and Colon Cancer Cells
Scientific Reports , , 2020 M20 | M21 |
2020 | Antonio Buzharevski, Svetlana Paskaš, Menyhárt-Botond Sárosi, Markus Laube, Peter Lönnecke, Wilma Neumann, Blagoje Murganić, Sanja Mijatović, Danijelа Maksimović-Ivanić, Jens Pietzsch & Evamarie Hey-Hawkins |
Odobren
|
|
| 3 |
CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase Pathway
ChemMedChem , , 2017 M20 | M21 |
2017 | MSc. Robert Kuhnert, Dr. Menyhárt-Botond Sárosi, Sven George, Dr. Peter Lönnecke, Dr. Bettina Hofmann, Prof. Dr. Dieter Steinhilber, Blagoje Murganic, Prof. Dr. Sanja Mijatovic, Prof. Dr. Danijela Maksimovic-Ivanic, Prof. Dr. Dr. h.c. mult. Evamarie Hey-Hawkins |
Odobren
|
|
| 4 |
Carborane-Based Analog of Rev-5901 Attenuates Growth of Colon Carcinoma In Vivo
Molecules , , 2022 M20 | M22 |
2022 | Svetlana Paskaš, Blagoje Murganić, Robert Kuhnert, Evamarie Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić |
Odobren
|
|
| 5 |
Carboranyl Analogues of Ketoprofen with Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines
ACS omega , , 2019 M20 | M22 |
2019 | Antonio BuzharevskiAntonio Buzharevski Institut für Anorganische Chemie, Universität Leipzig, Johannisallee 29, D-04103 Leipzig, Germany More by Antonio Buzharevski , Svetlana Paskas, Markus Laube, Peter Lönnecke, Wilma Neumann, Blagoje Murganic, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Jens Pietzsch, and Evamarie Hey-Hawkins* |
Odobren
|
|
| 6 |
Quinoline-Conjugated Ruthenacarboranes: Toward Hybrid Drugs with a Dual Mode of Action
ChemMedChem , , 2019 M20 | M22 |
2019 | Gozzi M, Murganic B, Drača D, Popp J, Coburger P, Maksimović-Ivanić D, Mijatović S, Hey-Hawkins E |
Odobren
|
|
| 7 |
TARGETING OF INFLAMMATION-CONNECTED TUMORS BY CARBORANECONJUGATED ROFECOXIB ANALOGS
IMMUNOLOGY AT THE CONFLUENCE OF MULTIDISCIPLINARY APPROACHES , Belgrade, Serbia , 2019 M30 | M34 |
2019 | Blagoje Murganić , Antonio Buzharevski , Svetlana Paskaš , Menyhárt-Botond Sárosi , Markus Laube , Peter Lönnecke , Wilma Neumann , Sanja Mijatović , Jens Pietzsch, Evamarie Hey-Hawkins , Danijelа Maksimović-Ivanić |
Odobren
|
|
| 8 |
Antitumorska svojstva inhibitora lipooksigenaze (LOX), REV5901
VII naučni sastanak Društva imunologa Srbije , Beograd, Srbija , 2016 M60 | M64 |
2016 | Blagoje Murganić, Robert Kuhnert, Eva Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić |
Odobren
|
|
| 9 |
DIFFERENCES IN CARBONIC ANHYDRASE 9 AND 12 EXPRESSION IN LUNG ADENOCARCINOMA AND LUNG SQUAMOUS CELL CARCINOMA
FIRST SERBIAN MOLECULAR MEDICINE CONGRESS , Foča , 2022 M30 | M34 |
2022 | Milica Nedeljkovic, Jelena Stojisic , Nasta Tanic, Blagoje Murganic, Tijana Tomic, Nejla Ademovic, Nikola Tanic |
Odobren
|
|
| 10 |
THE ROLE OF TP53 AND PTEN TUMOR SUPPRESSOR GENES IN RESPONSE TO DIFFERENT BREAST CANER TREATMENT MODALITES
FIRST SERBIAN MOLECULAR MEDICINE CONGRESS , Foča , 2022 M30 | M34 |
2022 | Nikola Tanic, Tatjana Dramićanin, Zorka Milovanović, Milica Nedeljković, Tijana Tomić, Neja Ademović, Blagoje Murganić, Nasta Tanić |
Odobren
|
|
| 11 |
Potential of Tamoxifen-based Copper(II) Dichloride in Breast Cancer Therapy
ONCOLOGY INSIGHTS , Beograd, Srbija , 2023 M30 | M34 |
2023 | Blagoje Murganić, Aleksandar Kazimir, Sanja Jelača, Nikola Tanić, Nasta Tanić, Evamarie Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić |
Odobren
|
|
| 12 |
Tamoxifen as a vector for platinum(II) and palladium(II) complexes in breast cancer treatment
The second serbian molecular medicine congress , Foča , 2023 M30 | M34 |
2023 | Blagoje Murganić, Aleksandar Kazimir, Sanja Jelača, Nikola Tanić, Nasta Tanić, Evamarie Hey-Hawkins, Sanja Mijatović, Danijela Maksimović-Ivanić |
Odobren
|
|
| 13 |
DETECTION OF GENOMIC INSTABILITY IN MALIGNANT BRAIN TUMORS
The Second Congress of Molecular Biologists of Serbia , Belgrade , 2023 M30 | M34 |
2023 | Nejla Ademović, Nasta Tanić, Tijana Tomić, Blagoje Murganić, Marina Milić, Nikola Tanić |
Odobren
|
|
| 14 |
Bipyraloxifene – a modified raloxifene vector against triple-negative breast cancer
RSC Medicinal Chemistry , , 2024 M20 | M22 |
2024 | Aleksandr Kazimir, Tom Götze, Blagoje Murganić, Sanja Mijatović, Danijela Maksimović-Ivanić, Evamarie Hey-Hawkins |
Odobren
|
|
| 15 |
Exploring Raloxifene‐Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple‐Negative Breast Cancer
ChemMedChem , , 2024 M20 | M22 |
2024 | Aleksandr Kazimir, Tom Götze, Peter Lönnecke, Blagoje Murganić, Sanja Mijatović, Danijela Maksimović‐Ivanić, Evamarie Hey‐Hawkins |
Odobren
|